Lataa...
Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects
Triple-negative breast cancer (TNBC), as defined by the absence of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 expression, is a challenging disease with the poorest prognosis of all breast cancer subtypes. Importantly, there are currently no known molecular...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3630481/ https://ncbi.nlm.nih.gov/pubmed/23634195 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834012475152 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|